Pfizer PFE announced that it is in-licensing exclusive global rights to develop, manufacture and commercialize YP05002, an ...
SiliconRepublic.com covered dozens of successful Irish start-up funding rounds this year. Here's a few notable ones.
New York City Mayor-elect Zohran Mamdani has reappointed Jessica Tisch as police commissioner, a woman directly responsible ...
BioNTech SE (NASDAQ:BNTX) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, Clear ...
Vaxcyte, Inc. (NASDAQ:PCVX) is one of the best biotech stocks to buy, according to Wall Street analysts. On December 8, the company confirmed the dosing of the first patients in its Phase 3 OPUS trial ...
What a SpaceX IPO could mean for Tesla shareholders, Pfizer pursuing next weight-loss drug in Chinese labs, more news to ...
Zacks Investment Research on MSN
Eli Lilly's next-generation obesity drug secures first phase III win
Shares of Eli Lilly LLY rose nearly 2% on Thursday after the company announced that a late-stage study evaluating its ...
A perfect storm of clinical setbacks, intensifying competition, and internal upheaval has triggered a historic sell-off in ...
The Goldman Sachs Group, Inc. is positioned to benefit from a lower interest rate environment. Learn more about GS stock here ...
(Removes extraneous word in paragraph 2) By Saeed Azhar, Lananh Nguyen and Manya Saini NEW YORK, Dec 9 (Reuters) - Goldman ...
Chief Financial Officer Denis Coleman said Tuesday that the company mergers-and-acquisitions business is on pace to sustain ...
Goldman Sachs Group Inc.’s stock is no longer a buy — even with a current surge in Wall Street dealmaking — because it’s too expensive and there are cheaper alternatives, according to an analyst at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results